By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Erlachstrasse 8

Berne 9    Ch-3000  Switzerland
Phone: 41-31-322-02-11 Fax: 41-31-322-02-12


Medical Device


Company News
Swissmedic Approves Akynzeo (netupitant/palonosetron) For Use In The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Switzerland 12/15/2015 6:33:07 AM
Swissmedic Accepts For Review CSL Behring's MAA For rIX-FP For Patients With Hemophilia B 7/28/2015 11:23:36 AM
Newron Pharmaceuticals (NWRN) Release: Safinamide Application For Authorization Submitted To Swissmedic 4/7/2014 4:04:26 PM
Swissmedic Accepts for Review Basilea Pharmaceutica (BSLN.SW)'s Ceftobiprole Marketing Authorization Application for the Treatment of Pneumonia 9/16/2013 9:33:00 AM
Osiris Therapeutics, Inc. (OSIR) Release: Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review 9/28/2012 10:25:38 AM
Apricus Biosciences (APRI) Submits Response to Swissmedic for Its Vitaros(R) Market Application for Erectile Dysfunction 6/14/2012 9:48:19 AM
Celgene International Sárl (CELG)'s REVLIMID(R) Granted Swissmedic Approval for Treatment of Rare Blood Cancer 11/21/2011 7:25:20 AM
Swissmedic Grants Approval for a Clinical Study of Neovacs SA's TNFa-kinoid Candidate for the Treatment of Crohn's Disease 6/2/2009 3:27:41 PM
Manhattan Pharmaceuticals, Inc. (MHTT) Receives Swissmedic's Approval To Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate 5/16/2006 12:40:11 PM
Manhattan Pharmaceuticals, Inc. (MHTP) Receives Swissmedic's Approval For Initiation Of Human Safety Trials For Oleoyl Estrone10/19/2005 5:12:30 PM